Biological Therapy Analysis & Statistics, October 2014 (p9)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

241-270 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014’, provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Mycosis Fungoides - Pipeline Review, H2 2014

Mycosis Fungoides - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Mycosis Fungoides - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mycosis Fungoides - Pipeline Review, H2 2014’, provides an overview of the Mycosis Fungoides’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
TheraDiag SA - Product Pipeline Analysis, 2014 Update

TheraDiag SA - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • October 2014
  • by Global Data

Summary Theradiag SA (Theradiag) is a biotechnology company. The company develops, manufactures, and markets in-vitro diagnostics. It offers product for the diagnostics of auto-immune diseases, allergies ...

  • Industries : Pathology, Diagnostics, Diagnostics
  • Countries : South Africa, Saudi Arabia
Stem Cell Therapeutics Markets

Stem Cell Therapeutics Markets

  • $ 3 995
  • Industry report
  • October 2014
  • by Kalorama Information

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. ...

  • Industries : Pathology, Biological Therapy, Pharmaceutical, Biotechnology
  • Countries : United States
Analysis of the Global Stem Cell Market

Analysis of the Global Stem Cell Market

  • $ 6 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

The key to Transforming Future of Diagnostic and Therapeutic Medicine This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the ...

  • Industries : Biological Therapy
  • Countries : South Korea, India, Singapore
Molecular Diagnostics Partnering Terms and Agreements

Molecular Diagnostics Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • October 2014
  • by Currentpartnering

Summary The Molecular Diagnostics Partnering Terms & Agreements provides comprehensive understanding and unprecedented access to the molecular diagnostics partnering deals and agreements entered into by ...

  • Industries : Pharmaceutical, Pathology, Healthcare, Diagnostics, Diagnostics, General Medicine and Specialty Medicine, Biotechnology, Medical Devices, Therapy
  • Countries : United States, North America
Regenerative Medicine Partnering Terms and Agreements

Regenerative Medicine Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • October 2014
  • by Currentpartnering

Summary The Regenerative Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, ...

  • Industries : Pharmaceutical, Healthcare, Biotechnology, Therapy
  • Countries : United States, North America
Lentigen Corporation - Product Pipeline Review - 2014, Global Markets Direct

Lentigen Corporation - Product Pipeline Review - 2014, Global Markets Direct

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

Lentigen Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Lentigen Corporation - Product Pipeline Review - 2014’, provides an overview of the Lentigen Corporation’s ...

  • Industries : Biopharmaceutical, Research and Development, Biotechnology, Pathology, Biological Therapy
  • Countries : United States
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014, Global Markets Direct

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014, Global Markets Direct

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014’, provides an overview ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cance ...

  • Industries : Pharmaceutical, Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : Europe, World
OpportunityAnalyzer: Allergic Rhinitis: Allergen-Specific Immunotherapy - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Allergic Rhinitis: Allergen-Specific Immunotherapy - Opportunity Analysis and Forecast to 2018

  • $ 7 995
  • Industry report
  • September 2014
  • by Global Data

OpportunityAnalyzer: Allergic Rhinitis: Allergen-Specific Immunotherapy - Opportunity Analysis and Forecast to 2018 Summary The global specific immunotherapy (SIT) market for allergic rhinitis (AR) is ...

  • Industries : Pathology, Pharmaceutical
  • Countries : Japan, Europe
Hospira, Inc. - Product Pipeline Review - 2014, Global Markets Direct

Hospira, Inc. - Product Pipeline Review - 2014, Global Markets Direct

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

Hospira, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Hospira, Inc. - Product Pipeline Review - 2014’, provides an overview of the Hospira, Inc.’s pharmaceutical research ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe
Multiple Sclerosis - Pipeline Review, H2 2014

Multiple Sclerosis - Pipeline Review, H2 2014

  • $ 2 500
  • Industry report
  • September 2014
  • by Global Markets Direct

Multiple Sclerosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H2 2014’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014’, provides an overview of the Graft Versus ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Healthcare, Pathology, Pharmaceutical
  • Countries : United States
Diabetic Retinopathy - Pipeline Review, H2 2014

Diabetic Retinopathy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Diabetic Retinopathy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Diabetic Retinopathy - Pipeline Review, H2 2014’, provides an overview of the Diabetic Retinopathy’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014, Global Markets Direct

JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014, Global Markets Direct

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014’, provides an overview of the JCR ...

  • Industries : Pharmaceutical
  • Countries : Japan, World
RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019

RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

The global transcriptomics market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has ...

  • Industries : Genomics, Biotechnology
  • Countries : World, Europe, North America
Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) - Forecast to 2019

Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) - Forecast to 2019

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

The global cell isolation market is expected to reach $5.1 billion by 2019 from $2.5 billion in 2014, growing at a CAGR of 15.8% from 2014 to 2019. The global cell isolation market is categorized on the ...

  • Industries : Biotechnology, Biological Therapy
  • Countries : World, Europe, North America
Cerebral Palsy - Pipeline Review, H2 2014

Cerebral Palsy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Cerebral Palsy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cerebral Palsy - Pipeline Review, H2 2014’, provides an overview of the Cerebral Palsy’s therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : United States
Epidermolysis Bullosa - Pipeline Review, H2 2014

Epidermolysis Bullosa - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Epidermolysis Bullosa - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Epidermolysis Bullosa - Pipeline Review, H2 2014’, provides an overview of the Epidermolysis Bullosa’s therapeutic ...

  • Industries : Pathology
  • Countries : United States, World, Europe
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

Over the years, the cell line development market has witnessed various technological advancements in order to cater to the growing demand for stable and high-yielding cell lines. These advancements have ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World, North America, Europe
International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy, Biotechnology, Investment Banking
  • Countries : United States, United Kingdom
Cellular Dynamics International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cellular Dynamics International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States
BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
  • Countries : United States
Cytori Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cytori Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
Vivalis SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Vivalis SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : South Africa, Saudi Arabia
NeoStem, Inc. (formerly Phase III Medical, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

NeoStem, Inc. (formerly Phase III Medical, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Healthcare
  • Countries : United States
Advanced Cell Technology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Advanced Cell Technology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States
SBI Biotech Co., Ltd. - Product Pipeline Review - 2014

SBI Biotech Co., Ltd. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

SBI Biotech Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘SBI Biotech Co., Ltd. - Product Pipeline Review - 2014’, provides an overview of the SBI Biotech Co., Ltd.’s ...

  • Industries : Biotechnology
  • Countries : World, United States, Japan
Cellectis S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cellectis S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.